The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like Should Biogen Buy Alkermes? February 27, 2018 Caribou Biosciences Appoints Ph.D. As Chief Scientific Officer July 5, 2017 Eleven Bio To Report Second Quarter 2017 Financial Results On Monday, August 14, 2017 August 6, 2017
